Drug related metabolites and genetic polymorphisms predict low low-density lipoprotein cholesterol response to atorvastatin treatment in patients with coronary heart disease von Munkhaugen, J, Sverre, E, Kristiansen, O, Fagerland, M.W, Peersen, K, Bergan, S, Gullestad, L, Husebye, E, Vethe, N.T

Volltext

Human PDAC-derived primary pancreatic stellate cells have minimum scavenging capacity due to lack of ability to uptake and process gemcitabine von Amrutkar, M., Vethe, N.T., Verbeke, C.S., Aasrum, M., Finstadsveen, A.V., Sántha, P., Gladhaug, I.P.

Volltext

Plasma concentration of atorvastatin metabolites correlates with low‐density lipoprotein cholesterol reduction in patients with coronary heart disease von Sverre, E., Munkhaugen, J., Kristiansen, O., Weedon‐Fekjær, H., Peersen, K., Gjertsen, E., Gullestad, L., Bergan, S., Husebye, E., Vethe, N. T.

Volltext

Personalized therapy for mycophenolate: consensus report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology von Bergan, S., Brunet, M., Hesselink, D.A., Johnson-Davis, K.L., Kunicki, P.K., Lemaitre, F., Marquet, P., Molinaro, M., Noceti, O., Pattanaik, S., Pawinski, T., Seger, C., Shipkova, M., Swen, J.J., Gelder, T. van, Venkataramanan, R., Wieland, E., Woillard, J.B., Zwart, T.C., Barten, M.J., Budde, K., Dieterlen, M.T., Elens, L., Haufroid, V., Masuda, S., Millan, O., Mizuno, T., Moes, D.J.A.R., Oellerich, M., Picard, N., Salzmann, L., Tonshoff, B., Schaik, R.H.N. van, Vethe, N.T., Vinks, A.A., Wallemacq, P., Asberg, A., Langman, L.J.

Volltext bestellen